Agilon Health Inc. (AGL) Tops Q2 EPS by 96c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mail
Get Alerts AGL Hot Sheet
Join SI Premium – FREE
Agilon Health Inc. (NYSE: AGL) reported Q2 EPS of $1.04, $0.96 better than the analyst estimate of $0.08. Revenue for the quarter came in at $1.49 billion versus the consensus estimate of $1.44 billion.
GUIDANCE:
Agilon Health Inc. sees Q3 2026 revenue of $1.44-1.47 billion, versus the consensus of $1.41 billion.
For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Levi (LEVI) Tops Q3 EPS by 12c; raises guidance
- HSBC Downgrades Rumo SA (RAIL3:BZ) to Hold
- Continental AG (CON:GR) (CTTAY) PT Raised to EUR82 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
